Filter

Refine by date

—

Refine by collections

  • Print
  • Save

Search Results

You are looking at 1 - 10 of 71 items for :

  • Thyroid remnant ablation x
Clear All
Ian D Hay Department of Medicine 1, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA

Search for other papers by Ian D Hay in
Google Scholar
PubMed Close
,
Suneetha Kaggal Department of Health Sciences Research, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA

Search for other papers by Suneetha Kaggal in
Google Scholar
PubMed Close
, and
Geoffrey B Thompson Department of Surgery, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA

Search for other papers by Geoffrey B Thompson in
Google Scholar
PubMed Close

thyroidectomy; PTC, papillary thyroid carcinoma; RNM, regional nodal metastases; RRA, radioiodine remnant ablation; Categorical variables are presented as number (%); a Kruskal–Wallis test P -value; b Chi-square test P -value. Details of the

Article Type:
Research Article
Collections:
Thyroid cancer - clinical
DOI:
https://doi.org/10.1530/ETJ-22-0084
Volume/Issue:
Volume 11: Issue 4
Open access
Nianting Ju Department of Nuclear Medicine, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China

Search for other papers by Nianting Ju in
Google Scholar
PubMed Close
,
Liying Hou Department of Nuclear Medicine, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China

Search for other papers by Liying Hou in
Google Scholar
PubMed Close
,
Hongjun Song Department of Nuclear Medicine, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China

Search for other papers by Hongjun Song in
Google Scholar
PubMed Close
,
Zhongling Qiu Department of Nuclear Medicine, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China

Search for other papers by Zhongling Qiu in
Google Scholar
PubMed Close
,
Yang Wang Department of Nuclear Medicine, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China

Search for other papers by Yang Wang in
Google Scholar
PubMed Close
,
Zhenkui Sun Department of Nuclear Medicine, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China

Search for other papers by Zhenkui Sun in
Google Scholar
PubMed Close
,
Quanyong Luo Department of Nuclear Medicine, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China

Search for other papers by Quanyong Luo in
Google Scholar
PubMed Close
, and
Chentian Shen Department of Nuclear Medicine, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China

Search for other papers by Chentian Shen in
Google Scholar
PubMed Close

international literature, including many guidelines ( 6 , 7 , 8 ), as the minimum level of TSH stimulation for radioiodine therapy including thyroid remnant ablation. However, there is no definite evidence yet that TSH level ≥ 30 mU/L is necessary for

Article Type:
Research Article
Collections:
Thyroid cancer - clinical
DOI:
https://doi.org/10.1530/ETJ-22-0219
Volume/Issue:
Volume 12: Issue 4
Open access
Fabián Pitoia Division of Endocrinology, Hospital de Clínicas, University of Buenos Aires, Buenos Aires, Argentina

Search for other papers by Fabián Pitoia in
Google Scholar
PubMed Close
,
Erika Abelleira Division of Endocrinology, Hospital de Clínicas, University of Buenos Aires, Buenos Aires, Argentina

Search for other papers by Erika Abelleira in
Google Scholar
PubMed Close
, and
Graciela Cross Division of Endocrinology, Hospital de Clínicas, University of Buenos Aires, Buenos Aires, Argentina

Search for other papers by Graciela Cross in
Google Scholar
PubMed Close

Introduction Remnant ablation is a traditional procedure that is usually performed after total thyroidectomy in patients with differentiated thyroid cancer (DTC) tumors >1 cm in diameter [ 1 , 2 ]. Numerous studies have confirmed that

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000369135
Volume/Issue:
Volume 3: Issue 4
Free access
Carolina C.P.S. Janovsky Thyroid Diseases Center and Laboratory of Molecular and Translational Endocrinology, Division of Endocrinology, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, São Paulo, Brazil

Search for other papers by Carolina C.P.S. Janovsky in
Google Scholar
PubMed Close
,
Rui M.B. Maciel Thyroid Diseases Center and Laboratory of Molecular and Translational Endocrinology, Division of Endocrinology, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, São Paulo, Brazil

Search for other papers by Rui M.B. Maciel in
Google Scholar
PubMed Close
,
Cleber P. Camacho Thyroid Diseases Center and Laboratory of Molecular and Translational Endocrinology, Division of Endocrinology, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, São Paulo, Brazil

Search for other papers by Cleber P. Camacho in
Google Scholar
PubMed Close
,
Rosalia P. Padovani Thyroid Diseases Center and Laboratory of Molecular and Translational Endocrinology, Division of Endocrinology, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, São Paulo, Brazil

Search for other papers by Rosalia P. Padovani in
Google Scholar
PubMed Close
,
Claudia C. Nakabashi Thyroid Diseases Center and Laboratory of Molecular and Translational Endocrinology, Division of Endocrinology, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, São Paulo, Brazil

Search for other papers by Claudia C. Nakabashi in
Google Scholar
PubMed Close
,
Ji H. Yang Thyroid Diseases Center and Laboratory of Molecular and Translational Endocrinology, Division of Endocrinology, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, São Paulo, Brazil

Search for other papers by Ji H. Yang in
Google Scholar
PubMed Close
,
Eduardo Z. Malouf Thyroid Diseases Center and Laboratory of Molecular and Translational Endocrinology, Division of Endocrinology, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, São Paulo, Brazil

Search for other papers by Eduardo Z. Malouf in
Google Scholar
PubMed Close
,
Elza S. Ikejiri Thyroid Diseases Center and Laboratory of Molecular and Translational Endocrinology, Division of Endocrinology, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, São Paulo, Brazil

Search for other papers by Elza S. Ikejiri in
Google Scholar
PubMed Close
,
M. Conceição O.C. Mamone Thyroid Diseases Center and Laboratory of Molecular and Translational Endocrinology, Division of Endocrinology, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, São Paulo, Brazil

Search for other papers by M. Conceição O.C. Mamone in
Google Scholar
PubMed Close
,
Jairo Wagner Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, São Paulo, Brazil

Search for other papers by Jairo Wagner in
Google Scholar
PubMed Close
,
Danielle M. Andreoni Thyroid Diseases Center and Laboratory of Molecular and Translational Endocrinology, Division of Endocrinology, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, São Paulo, Brazil

Search for other papers by Danielle M. Andreoni in
Google Scholar
PubMed Close
, and
Rosa Paula M. Biscolla Thyroid Diseases Center and Laboratory of Molecular and Translational Endocrinology, Division of Endocrinology, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, São Paulo, Brazil

Search for other papers by Rosa Paula M. Biscolla in
Google Scholar
PubMed Close

follow-up care [ 2 , 7 , 8 ]. The treatment of differentiated thyroid cancer usually consists of total thyroidectomy (TT) and radioiodine remnant ablation (RRA) [ 4 , 8 ]. The rationale for the use of RRA comprises: remnant ablation, to facilitate the

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000442048
Volume/Issue:
Volume 5: Issue 1
Free access
Furio Pacini Department of Medical, Surgical and Neurological Sciences, University of Siena, Siena, Italy

Search for other papers by Furio Pacini in
Google Scholar
PubMed Close

131 I. The aim of postsurgical ablation of the thyroid remnant with RAI is to facilitate the early detection of recurrence based on serum thyroglobulin (Tg) measurement and RAI whole body scan. In addition, RAI ablation may represent an adjuvant

Article Type:
Editorial
DOI:
https://doi.org/10.1159/000442880
Volume/Issue:
Volume 5: Issue 1
Free access
Beng Khiong Yap The Christie NHS Foundation Trust

Search for other papers by Beng Khiong Yap in
Google Scholar
PubMed Close
,
Jarrod Homer Central Manchester NHS Foundation Trust

Search for other papers by Jarrod Homer in
Google Scholar
PubMed Close
,
Neil Parrott Central Manchester NHS Foundation Trust

Search for other papers by Neil Parrott in
Google Scholar
PubMed Close
,
Sean Loughran Central Manchester NHS Foundation Trust

Search for other papers by Sean Loughran in
Google Scholar
PubMed Close
,
Brian Murby The Christie NHS Foundation Trust

Search for other papers by Brian Murby in
Google Scholar
PubMed Close
,
Ric Swindell The Christie NHS Foundation Trust

Search for other papers by Ric Swindell in
Google Scholar
PubMed Close
, and
Ashu Gandhi University of Manchester, Manchester Academic Health Science Centre, University Hospital of South Manchester NHS Foundation Trust, Manchester, UK

Search for other papers by Ashu Gandhi in
Google Scholar
PubMed Close

remove the primary tumour and thyroid tissue to facilitate post-operative remnant ablation with radioactive iodine-131 (RAI). The role of RAI is twofold: firstly to ablate the residual normal thyroid remaining after total thyroidectomy, thus facilitating

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000355911
Volume/Issue:
Volume 2: Issue 4
Free access
Nicholas S. Andresen Department of Radiation Oncology, University of Iowa, Iowa City, Iowa, USA

Search for other papers by Nicholas S. Andresen in
Google Scholar
PubMed Close
,
John M. Buatti Department of Radiation Oncology, University of Iowa, Iowa City, Iowa, USA

Search for other papers by John M. Buatti in
Google Scholar
PubMed Close
,
Hamed H. Tewfik Iowa City Cancer Treatment Center, Iowa City, Iowa, USA

Search for other papers by Hamed H. Tewfik in
Google Scholar
PubMed Close
,
Nitin A. Pagedar Department of Otolaryngology-Head and Neck Surgery, University of Iowa, Iowa City, Iowa, USA

Search for other papers by Nitin A. Pagedar in
Google Scholar
PubMed Close
,
Carryn M. Anderson Department of Radiation Oncology, University of Iowa, Iowa City, Iowa, USA

Search for other papers by Carryn M. Anderson in
Google Scholar
PubMed Close
, and
John M. Watkins Department of Radiation Oncology, University of Iowa, Iowa City, Iowa, USA

Search for other papers by John M. Watkins in
Google Scholar
PubMed Close

not be indicated [ 7 , 8 ], and recent phase III trials have demonstrated equivalent rates of thyroid remnant ablation with 30 versus 100 mCi doses of RAI [ 9 , 10 ], practice patterns remain highly variable by individual practitioner [ 11 ]. The

Article Type:
Review Article
DOI:
https://doi.org/10.1159/000468927
Volume/Issue:
Volume 6: Issue 4
Free access
Laura Agate Endocrinology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy

Search for other papers by Laura Agate in
Google Scholar
PubMed Close
,
Francesca Bianchi Unit of Endocrine and Oncological Nuclear Medicine Therapy, Diagnostic and Imaging Department, University of Pisa, Pisa, Italy

Search for other papers by Francesca Bianchi in
Google Scholar
PubMed Close
,
Federica Brozzi Unit of Endocrine and Oncological Nuclear Medicine Therapy, Diagnostic and Imaging Department, University of Pisa, Pisa, Italy

Search for other papers by Federica Brozzi in
Google Scholar
PubMed Close
,
Pierina Santini Unit of Endocrine and Oncological Nuclear Medicine Therapy, Diagnostic and Imaging Department, University of Pisa, Pisa, Italy

Search for other papers by Pierina Santini in
Google Scholar
PubMed Close
,
Eleonora Molinaro Endocrinology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy

Search for other papers by Eleonora Molinaro in
Google Scholar
PubMed Close
,
Valeria Bottici Endocrinology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy

Search for other papers by Valeria Bottici in
Google Scholar
PubMed Close
,
David Viola Endocrinology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy

Search for other papers by David Viola in
Google Scholar
PubMed Close
,
Loredana Lorusso Endocrinology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy

Search for other papers by Loredana Lorusso in
Google Scholar
PubMed Close
,
Paolo Vitti Endocrinology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy

Search for other papers by Paolo Vitti in
Google Scholar
PubMed Close
, and
Rossella Elisei Endocrinology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy

Search for other papers by Rossella Elisei in
Google Scholar
PubMed Close

Introduction Until a few years ago, the standard therapy of well-differentiated thyroid cancer (DTC) consisted of total or near total thyroidectomy followed by radioiodine (RAI) remnant ablation (RRA) and TSH suppressive levothyroxine (LT4

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000494290
Volume/Issue:
Volume 8: Issue 2
Free access
Germán A. Jimenez Londoño Nuclear Medicine Department, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain

Search for other papers by Germán A. Jimenez Londoño in
Google Scholar
PubMed Close
,
Ana Maria Garcia Vicente Nuclear Medicine Department, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain

Search for other papers by Ana Maria Garcia Vicente in
Google Scholar
PubMed Close
,
Julia Sastre Marcos Department of Endocrinology, Complejo Hospitalario de Toledo, Toledo, Spain

Search for other papers by Julia Sastre Marcos in
Google Scholar
PubMed Close
,
Francisco Jose Pena Pardo Nuclear Medicine Department, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain

Search for other papers by Francisco Jose Pena Pardo in
Google Scholar
PubMed Close
,
Mariano Amo-Salas Department of Mathematics, University of Castilla-La Mancha, Ciudad Real, Spain

Search for other papers by Mariano Amo-Salas in
Google Scholar
PubMed Close
,
Manuel Moreno Caballero Department of Nuclear Medicine, Hospital Universitario Infanta Cristina Badajoz, Badajoz, Spain

Search for other papers by Manuel Moreno Caballero in
Google Scholar
PubMed Close
,
Maria Prado Talavera Rubio  Nuclear Medicine Department, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain

Search for other papers by Maria Prado Talavera Rubio  in
Google Scholar
PubMed Close
,
Beatriz Gonzalez Garcia Nuclear Medicine Department, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain

Search for other papers by Beatriz Gonzalez Garcia in
Google Scholar
PubMed Close
,
Niletys Dafne Disotuar Ruiz Nuclear Medicine Department, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain

Search for other papers by Niletys Dafne Disotuar Ruiz in
Google Scholar
PubMed Close
, and
Angel Maria Soriano Castrejón Nuclear Medicine Department, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain

Search for other papers by Angel Maria Soriano Castrejón in
Google Scholar
PubMed Close

many patients undergo radioiodine remnant ablation (RRA) to eliminate the residual normal thyroid tissue after total thyroidectomy (TT) or near TT (NTT). Previous works [ 3 - 5 ] have shown that a low dose of 131-I is as effective as a high dose for

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000489850
Volume/Issue:
Volume 7: Issue 4
Free access
F. Cecoli Endocrinology, Nuclear Medicine and Autoimmunity Laboratory, Department of Internal Medicine, and Department of Experimental Medicine, Genoa University, and IRCCS Azienda Ospedaliera Universitaria San Martino - IST Genoa

Search for other papers by F. Cecoli in
Google Scholar
PubMed Close
,
E.M. Ceresola Endocrinology, Nuclear Medicine and Autoimmunity Laboratory, Department of Internal Medicine, and Department of Experimental Medicine, Genoa University, and IRCCS Azienda Ospedaliera Universitaria San Martino - IST Genoa

Search for other papers by E.M. Ceresola in
Google Scholar
PubMed Close
,
V. Altrinetti Endocrinology and Nuclear Medicine, Galliera Hospital, Genoa

Search for other papers by V. Altrinetti in
Google Scholar
PubMed Close
,
M. Cabria Endocrinology and Nuclear Medicine, Galliera Hospital, Genoa

Search for other papers by M. Cabria in
Google Scholar
PubMed Close
,
M. Cappagli Endocrine Unit, Sant'Andrea Hospital, La Spezia

Search for other papers by M. Cappagli in
Google Scholar
PubMed Close
,
A. Montepagani Endocrine Unit, Sant'Andrea Hospital, La Spezia

Search for other papers by A. Montepagani in
Google Scholar
PubMed Close
,
C.M. Cuttica Endocrinology and Nuclear Medicine, Galliera Hospital, Genoa

Search for other papers by C.M. Cuttica in
Google Scholar
PubMed Close
,
U. Filippi Evangelico Internazionale Hospital, Genoa

Search for other papers by U. Filippi in
Google Scholar
PubMed Close
,
D. Saverino Endocrinology, Nuclear Medicine and Autoimmunity Laboratory, Department of Internal Medicine, and Department of Experimental Medicine, Genoa University, and IRCCS Azienda Ospedaliera Universitaria San Martino - IST Genoa

Search for other papers by D. Saverino in
Google Scholar
PubMed Close
,
M. Raffa Endocrine-Metabolic Center, ASL 1, Imperia, Italy

Search for other papers by M. Raffa in
Google Scholar
PubMed Close
,
M. Caputo Endocrinology, Nuclear Medicine and Autoimmunity Laboratory, Department of Internal Medicine, and Department of Experimental Medicine, Genoa University, and IRCCS Azienda Ospedaliera Universitaria San Martino - IST Genoa

Search for other papers by M. Caputo in
Google Scholar
PubMed Close
,
F. Minuto Endocrinology, Nuclear Medicine and Autoimmunity Laboratory, Department of Internal Medicine, and Department of Experimental Medicine, Genoa University, and IRCCS Azienda Ospedaliera Universitaria San Martino - IST Genoa

Search for other papers by F. Minuto in
Google Scholar
PubMed Close
,
M. Giusti Endocrinology, Nuclear Medicine and Autoimmunity Laboratory, Department of Internal Medicine, and Department of Experimental Medicine, Genoa University, and IRCCS Azienda Ospedaliera Universitaria San Martino - IST Genoa

Search for other papers by M. Giusti in
Google Scholar
PubMed Close
, and
M. Bagnasco Endocrinology, Nuclear Medicine and Autoimmunity Laboratory, Department of Internal Medicine, and Department of Experimental Medicine, Genoa University, and IRCCS Azienda Ospedaliera Universitaria San Martino - IST Genoa

Search for other papers by M. Bagnasco in
Google Scholar
PubMed Close

Practice for the Diagnosis and Management of Thyroid Nodules. Endocr Pract 2010;16:1-43. 10.4158/10024.GL 20497938 22 Lamartina L, Durante C, Filetti S, Cooper DS: Low-risk differentiated thyroid cancer and radioiodine remnant ablation: a systematic

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000446746
Volume/Issue:
Volume 5: Issue 3
Free access